ArticlePDF Available

Huang ZG, Xue D, Preston E, Karbalai H & Buchan AM.Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci 26: 298−304

Authors:

Abstract

Tracer constants (Ki) for blood-to-brain diffusion of sucrose were measured in the rat to profile the time course of blood-brain barrier injury after temporary focal ischemia, and to determine the influence of post-ischemic hypothermia. Spontaneously hypertensive rats were subjected to transient (2 hours) clip occlusion of the right middle cerebral artery. Reperfusion times ranged from 1.5 min to 46 hours, and i.v. 3H-sucrose was circulated for 30 min prior to each time point (1 h, 4 h, 22 h, and 46 h; n = 5-7 per time point). Ki was calculated from the ratio of parenchymal tracer uptake and the time-integrated plasma concentration. Additional groups of rats (n = 7-8) were maintained either normothermic (37.5 degrees C) or hypothermic (32.5 degrees C or 28.5 degrees C) for the first 6 hours of reperfusion, and Ki was measured at 46 hours. Rats injected after 1.5-2 min exhibited a 10-fold increase in Ki for cortical regions supplied by the right middle cerebral artery (p < 0.01). This barrier opening had closed within 1 to 4 hours post-reperfusion. By 22 hours, the blood-brain barrier had re-opened, with further opening 22 and 46 hours (p < 0.01), resulting in edema. Whole body hypothermia (28 degrees C-29 degrees C) during the first six hours of reperfusion prevented opening, reducing Ki by over 50% (p < 0.05). Transient middle cerebral artery occlusion evokes a marked biphasic opening of the cortical blood-brain barrier, the second phase of which causes vasogenic edema. Hypothermic treatment reduced infarct volume and the late opening of the blood-brain barrier. This opening of the blood-brain barrier may enhance delivery of low permeability neuroprotective agents.
298
ABSTRACT: Objective: Tracer constants (K
i
) for blood-to-brain diffusion of sucrose were measured in the rat to profile the time
course of blood-brain barrier injury after temporary focal ischemia, and to determine the influence of post-ischemic hypothermia.
Methods: Spontaneously hypertensive rats were subjected to transient (2 hours) clip occlusion of the right middle cerebral artery.
Reperfusion times ranged from 1.5 min to 46 hours, and i.v.
3
H-sucrose was circulated for 30 min prior to each time point (1h, 4h, 22h,
and 46h; n=5-7 per time point). K
i
was calculated from the ratio of parenchymal tracer uptake and the time-integrated plasma
concentration. Additional groups of rats (n=7-8) were maintained either normothermic (37.5
o
C) or hypothermic (32.5
o
C or 28.5
o
C) for
the first 6 hours of reperfusion, and K
i
was measured at 46 hours. Results: Rats injected after 1.5 – 2 min exhibited a 10-fold increase
in K
i
for cortical regions supplied by the right middle cerebral artery (p<0.01). This barrier opening had closed within 1 to 4 hours post-
reperfusion. By 22 hours, the blood-brain barrier had re-opened, with further opening 22 and 46 hours (p<0.01), resulting in edema.
Whole body hypothermia (28
o
C-29
o
C) during the first six hours of reperfusion prevented opening, reducing K
i
by over 50% (p<0.05).
Conclusions: Transient middle cerebral artery occlusion evokes a marked biphasic opening of the cortical blood-brain barrier, the
second phase of which causes vasogenic edema. Hypothermic treatment reduced infarct volume and the late opening of the blood-brain
barrier. This opening of the blood-brain barrier may enhance delivery of low permeability neuroprotective agents.
RÉSUMÉ: Ouverture biphasique de la barrière hémato-encéphalique suite à une ischémie focale transitoire: effets de lhypothermie. Objectif:
Nous avons mesuré les constantes d’un traceur (K
i
) de la diffusion de sucrose du sang vers le cerveau chez le rat afin d’observer l’évolution des
dommages subis par la barrière hémato-encéphalique après une ischémie focale temporaire et pour déterminer les effets d’une hypothermie post-
ischémique. Méthodes: Des rats spontanément hypertendus ont été soumis à une occlusion de deux heures de l’artère cérébrale moyenne par un clip.
Le temps de reperfusion variait de 1.5 minute à 46 heures et une perfusion intraveineuse de
3
H-sucrose a été administrée pendant 30 minutes avant
chaque évaluation ponctuelle (1h, 4h, 22h, et 46h; n=5-7 par évaluation ponctuelle). La constante K
i
a été calculée à partir de l’indice de captation du
traceur par le parenchyme et de la concentration plasmatique en fonction du temps. Des groupes additionnels de rats (n=7-8) ont été maintenus soit à
la température normale (37.5
o
C) ou en hypothermie (32.5
o
C ou 28.5
o
C) pendant les 6 premières heures de la reperfusion et K
i
a été mesurée à 46 heures.
Results: Les rats qui ont reçu l’injection après 1.5 – 2 minutes présentaient une augmentation de K
i
de dix fois supérieure dans les régions corticales
irriguées par l’artère cérébrale moyenne (p<0.01). Cette ouverture de la barrière s’était refermée 1 à 4 heures post-reperfusion. À 22 heures, la barrière
hémato-encéphalique s’était réouverte, davantage à 22 et à 46 heures (p<0.01), ce qui a donné lieu à de l’œdème. L’hypothermie généralisée (28
o
C -
29
o
C) pendant les 6 premières heures de la reperfusion a empêché son ouverture, diminuant ainsi la constante K
i
de plus de 50% (p<0.05). Conclusions:
L’occlusion transitoire de l’artère cérébrale moyenne provoque une ouverture biphasique importante de la barrière hémato-encéphalique corticale dont
la deuxième phase cause de l’œdème. L’hypothermie a diminué la taille de l’infarctus cérébral et l’ouverture tardive de la barrière hémato-encéphalique.
Cette ouverture de la barrière hémato-encéphalique peut accroître la distribution d’agents neuroprotecteurs à basse perméabilité.
Can. J. Neurol. Sci. 1999; 26: 298-304
Brain capillary walls are distinguished by an endothelial cell
layer replete with tight junctions and a scarcity of fenestrae. This
blood-brain barrier (BBB) is a specialization which maintains
homeostasis of the neuronal micro-environment, limiting blood-
to-brain diffusion of hydrophilic molecules. Penetration is
largely restricted to lipophilic substances capable of directly
traversing endothelial membranes, and to hydrophilic substances
such as amino acids and glucose, for which specific membrane
carriers exist.
1,2
BBB drainage, following brain ischemia, leads
to the extravascular leakage of plasma proteins and other solutes,
resulting in an imbalance with osmotic forces drawing excess
water into the tissue (i.e. vasogenic edema).
3
Tissue swelling
ensues within the rigid confines of the skull, elevating
intracranial pressure with secondary ischemia due to
compression of microvasculature, and, ultimately, brain
herniation.
4
Biphasic Opening of the Blood-Brain
Barrier Following Transient Focal
Ischemia: Effects of Hypothermia
Z. Gao Huang, Dong Xue, Edward Preston, Hasneen Karbalai,
Alastair M. Buchan
From the Alberta Stroke Program, Department of Clinical Neurosciences, University
of Calgary, Alberta, (ZGH ,DX, HK, AMB); and the Institute for Biological Sciences,
National Research Council, Ottawa, Ontario, Canada (ZGH, DX, EP)
RECEIVED JANUARY 9, 1999. ACCEPTED IN FINAL FORM MAY 18, 1999
Reprint requests to: Alastair M. Buchan, Alberta Stroke Program, Office of Stroke
Research, Room 1162, Foothills Hospital, 1403 – 29th Street NW, Calgary, AB,
Canada T2N 2T9
EXPERIMENTAL
NEUROSCIENCES
A reproducible rodent model used to study focal brain
ischemia involves temporary (e.g. 0.5 to 4 hours, or permanent
occlusion of a middle cerebral artery [MCAO model] with
tandem occlusion of the ipsilateral common carotid artery).
5,6,7
Temporary MCAO enables the study of both positive and
negative aspects of post-ischemic reperfusion, which occurs
clinically, both spontaneously and therapeutically, with the
advent of r-tPA, newly licensed as a thrombolytic agent for
ischemic stroke in the first three hours. Restoration of blood
flow, if early enough, may offer the advantage of reducing
neuronal damage and limiting infarct extension and enhances
potentially cytoprotective drug delivery. These benefits may be
undermined by reperfusion injury to the microvasculature,
compromising BBB function, exacerbating edema formation and
the inflammatory developments that follow.
2,3,4
Dynamic
changes in BBB permeability, which follow temporary MCAO,
are therefore of critical importance.
The objective of this study was to delineate the time course
and intensity of the BBB opening after reversible MCAO
ischemia in the rat using a method involving a removable,
atraumatic clip.
6
Post ischemic changes in the BBB were studied
using a modification
8
of a radiotracer methodology, which
quantifies even minor degrees of BBB opening with a high
degree of sensitivity.
9,10
The radiotracer method used in this
study is based on a 2-compartment (plasma/brain) simple
diffusion model, which assumes that the amount of
3
H-sucrose,
which permeates the microvasculature into brain parenchyma,
does so in proportion to the time integral of plasma tracer
concentration. Normal BBB permeability and opening are
indexed in the ratio of parenchymal uptake relative to plasma
integral, calculated as the transfer constant, K
i
.
9,10
The effects of
delayed hypothermia
11
on the biphasic BBB opening were also
investigated.
METHODS AND MATERIALS
Male spontaneously hypertensive rats (SHR) weighing 170g
– 225g were fasted for 18 hours prior to surgery, but allowed free
access to water. Animals were initially anesthetized with 3%
halothane, and subsequently maintained on 1 – 2% halothane
mixed with 70% nitrogen and 28% oxygen. Body temperature
was maintained at 37.5
o
C
±
0.5
o
C during surgery, by rectal
thermistor coupled to a heating lamp.
The method for producing reversible focal ischemia has been
fully described.
6
The right common carotid artery was isolated
through a ventral midline neck incision and ligated. A 1cm
incision was made perpendicular to and bisecting a line between
the lateral canthus and the right eye and the external auditory
canal. The underlying temporalis muscle was partially excised. A
burr hole, 1 mm in diameter, was drilled 2 – 3 mm rostral to the
point of fusion of the zygomatic arch with the temporal bone.
Drilling was accompanied by a gentle drip of isotonic saline to
prevent warming of the underlying cortex. The dura over the
MCA was then cut and retracted. A #1 micro-clip (Codman) was
placed on the MCA at a site proximal to the point where it
crosses the inferior cerebral vein in the rhinal fissure. The
incisions were then closed with wound clips.
Animals were subjected to two hours of ischemia, during
which time the anesthesia was discontinued and the animals
allowed to regain consciousness. At the end of ischemia, the rats
were briefly re-anesthetized with halothane, the MCA clip
removed, and blood re-flow through the MCA visually verified.
The wound was sutured closed, and the animal permitted to
regain consciousness. Sham groups of animals were treated in
the same manner, except the micro-clip was placed on the MCA
and then removed immediately. Animals were maintained at a
rectal temperature of 37
o
C - 38
o
C for all procedures, except
where indicated otherwise in the hypothermic experiments.
Regional transfer constants (K
i
) for BBB permeation of
3
H-
sucrose were measured by a previously published method.
8,10
modified after 9
Measurements were made at different time points
after reperfusion of the right MCA. The rats were anesthetized
with pentobarbital (65 mg/kg i.p.) and, after cannulation of a
femoral artery and vein,
3
H-sucrose (NET-341) was injected
intravenously (20 µCi/100g, in 0.5 ml saline). Immediately upon
tracer injection, syringe-pump sampling of femoral arterial blood
was begun at a constant rate (0.039 ml/min
-1
) and continued for
30 min. At this point, sampling was stopped and the brain was
immediately cleared of intravascular tracer
8
by perfusing 25 ml
saline at 100 – 130 mm Hg pressure through a cannula inserted a
few minutes beforehand into the right carotid artery.
12
The rat
was decapitated, the brain removed and dissected bilaterally into
the cortex (about 180 mm
3
, representing the complete MCA
supply territory), striatum, and hippocampus. Brain samples
(weighed) and measured volumes of plasma from the arterial
sample were placed in the scintillation vials and solubilized
overnight at 37.5
o
C in 1.3 ml Soluene 350 (Packard Instr.). 10 ml
of fluor (HionicFluor) was added to all vials and the samples
were counted by liquid scintillation to determine the tracer level
in the brain parenchyma (C
paren
, dpm.g
-1
) and the time integral of
the plasma tracer level (α
1800
C
plasma
dt, dpm.s.ml
-1
). The integral
was obtained by multiplying the plasma concentration (C
plasma,
dpm.ml
-1
) by the circulation time (1800s). The transfer constant
(K
i
, mL.g
-1
.s
-1
) was calculated from the relationship: K
i
=
C
paren
/α
1800
C
plasma
dt.
9
In Experiment 1, radiotracer studies were carried out at 1, 4,
22, and 46 hours after reperfusion (or 3, 6, 24, and 48 hours after
the onset of ischemia) with five animals in each group. In an
additional group (n = 5), the radiotracer experiments were
initiated within 1.5 – 2 min after reperfusion. In this case only,
pentobarbital rather than halothane, anesthesia was induced 15
min before reperfusion for cannulations and clip removal. A
group of sham-operated rats (n = 7 total) was studied at 1, 2, 3,
5, and 24 hours after sham occlusion, with one or two rats at each
time point. No sham-operated rats were studied at 1.5 - 2
minutes.
In Experiment 2, rats underwent mild or moderate
hypothermia during the first 6 hours of reperfusion. Ten minutes
before the end of 2 hours of MCA occlusion, the rats were lightly
halothane anesthetized and were surrounded by bags of crushed
ice. This caused body temperature to drop to 32
o
C - 33
o
C at the
time that the MCA clip was removed. Rectal temperature was
maintained for 6 hours at 32
o
C - 33
o
C for the mild hypothermic
group (n=7) or 28
o
C - 29
o
C for the moderate hypothermic group
(n=7). Control animals, maintained at 37
o
C - 38
o
C, were
concurrently studied with their hypothermic peers, such that two
normothermic groups were formed (n = 8 for the mild
hypothermia controls, and n = 7 for the moderate hypothermia
controls). During the six hours, halothane was continued at 0.5 –
0.7% for the hypothermia groups only, as the control group did
Volume 26, No. 4 – November 1999
299
LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES
not require anesthesia during reperfusion. Afterwards, these
animals were permitted to recover from anesthesia and return to
normothermic conditions. Radiotracer experiments were carried
out at 46 hours post-reperfusion.
In Experiment 3, to assess edema development after two hours
of MCA occlusion, rats were sacrificed by decapitation after 4 (n
= 5), and 46 (n = 6) hours of reperfusion. Samples of right and left
cortex were dissected out and the percentage water content was
obtained by weight difference after complete oven drying. The
effect of 6 hours post-reperfusion hypothermia was also examined
in relation to edema formation. Six rats were subjected to 6 hours
of post-reperfusion moderate hypothermia (28
o
C - 29
o
C) followed
by 40 hours of normothermia (37
o
C - 38
o
C).
In Experiment 4, neocortical infarct volume was measured in
separate animals to determine the effect of hypothermia after
MCAO. Rats underwent two hours of ischemia and were then
kept either normothermic (n = 6), or immediately underwent 6
hours of mild (32
o
C - 33
o
C, n = 6) or moderate (28
o
C - 29
o
C, n
= 6) hypothermia, as above. Rats were anesthetized and
decapitated after 46 hours of reperfusion and the brains removed
and frozen. Coronal sections, 20 µm thick, were cut at -25
o
C, and
every 25th section was saved. The sections were stained with
hematoxylin and eosin, and infarct volume and edema were
obtained with an image processing system (Image-Pro II). Infarct
area of each section was traced, and the total infarct volume was
calculated by summing the infarcted area of sequential sections
and multiplying the interval thickness between sections. Edema
was calculated by comparing the increase in size of the right
hemisphere as compared to the left hemisphere.
Statistical analyses used in the transfer constant and edema
studies were the ANOVA plus Tukey’s test. A two-tailed
Student’s t test was used to compare cortical infarct volumes in
hypothermic versus control animals. A p-value of less than 0.05
was taken to indicate statistical significance. All values are
presented as ± SD.
R
ESULTS
Experiment 1
Mean regional transfer constants for the six groups of
normothermic rats are summarized in Table 1. In 7 sham-stroked
rats, radiotracer measurements were initiated at 1, 2, 3, 5, or 24
hours after the sham procedure. Each time period group
contained 1 animal, except for the 3 and 24 hour groups, which
contained 2 animals each. There were no significant differences
between the regional K
i
values for cerebral tissues on the right
side of the brain (which had undergone a complete surgical
procedure, except for MCA occlusion), and those of
corresponding territories on the left side. In the 5 experimental
groups of rats which underwent 2 hours of MCA occlusion (each
group: n = 5), the largest blood-brain barrier openings and
increases in K
i
took place in the right neocortical tissue supplied
by the occluded right MCA (Table 1). When the 30 min tracer
circulation period began 1.5 – 2 min after reperfusion, there was
evidence of an early increase in mean K
i
to greater than 10-fold
of the baseline value. This was followed by a partial recovery,
with subsequent K
i
measurements and 1 and 4 hours post-
reperfusion, which were significantly lower than the acute (1.5 –
2 min) group values, although still elevated above baseline and
above values for the contralateral, non-ischemic side. A late
opening in the BBB was then demonstrated 4 and 22 hours post-
reperfusion. This was most pronounced between 22 and 46 hours
(Figure 1).
Striatum removed from the right hemisphere of stroked rats
exhibited a slight but significant elevation in K
i
, 1.3 – 2 min post-
reperfusion (Table 1). This change was no longer present at 1 or
4 hours post-reperfusion, however, a significant increase in K
i
was demonstrated between 22 and 46 hours after reperfusion.
The dorsal hippocampus ipsilateral to the MCA occlusion
showed little change in K
i
, except at the 46 hour time point, when
a slight elevation was present. In the contralateral, non-ischemic
Table 1: Regional Transfer Constant (K
i
) in MCA Model (Experiment 1)
Right Left
(Mean ± SD) (mL.g
-1
.s
-1
x 10
6
) (Mean ± SD) (mL.g
-1
.s
-1
x 10
6
)
Variability Cortex Striatum Hippocampus Cortex Striatum Hippocampus
Group (n)
Sham (7) 1.6 ± 0.8
b
1.3 ± 0.6
b
1.7 ± 0.7 1.9 ± 0.4 1.3 ± 0.3 1.9 ± 0.3
Immediate (5) 17.3 ± 11.9
abc
3.4 ± 1.0
a
2.8 ± 1.0 2.8 ± 1.0
d
2.2 ± 0.6 3.0 ± 1.1
RP-1 Hour (5) 5.7 ± 4.1
ac
2.4 ± 1.0 2.3 ± 0.9 2.3 ± 0.4
d
1.9 ± 0.8 2.1 ± 0.4
RP-4 Hours (5) 5.9 ± 2.9
ab
2.7 ±1.9 2.0 ± 1.0 3.0 ± 1.4 2.1 ± 1.1 2.7 ± 1.1
RP-22 Hours (5) 13.1 ± 2.0
abc
5.3 ± 1.0
ab
2.4 ± 0.5
b
2.3 ± 0.7
d
1.6 ± 0.4
d
2.3 ± 0.9
RP-46 Hours(5) 59.0 ± 9.3
ac
16.5 ± 6.8
a
6.0 ± 2.6
a
2.5 ± 0.8
d
2.1 ± 0.78
d
2.7 ± 0.8
p<0.05 for ANOVA plus Tukey’s test.
Within tissues and between treatments: a – different from control (sham stroke) value; b – different from value immediately below.
Within treatments and between tissues: c – different from all other values; d – left side values different from corresponding right side values.
300
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES
Volume 26, No. 4 – November 1999
301
hemisphere, all regions exhibited mean K
i
values slightly higher
then the baseline, sham stroke values. However, in no instance
was this statistically significant.
Experiment 2
Table 2 shows the effect of mild or moderate hypothermia for
6 hours post-reperfusion on BBB opening caused by MCAO.
Mean K
i
measured 46 hours post-reperfusion was lower in rats
that underwent hypothermia (32
o
C - 33
o
C) compared to that of
normothermic controls. With moderate hypothermia of 28
o
C -
29
o
C, the reduction in BBB opening was more striking.
Experiment 3
Table 3 reports edema measurements based on the wet to dry
weight difference as a percentage of water per cerebral
hemisphere (ml.g
-1
x 100). In 5 rats sacrificed 4 hours post-
reperfusion, the values (mean ± SD) were 80.4 ± 0.3% and 78.5
± 0.2% for the right and left sides, respectively (p<0.001).
Furthermore, the mean % H
2
O measured in the stroked
hemisphere at 22 hours post-reperfusion was significantly higher
than that at 4 hours (p< 0.01), whereas, in the non-ischemic
hemisphere there was no significant difference between these
two time points.
Table 2: Effect of Mild and Moderate Post-Ischemic Hypothermia on Transfer Constant (K
i
) (Experiment 2)
Right Left
(Mean ± SD) (mL.g
-1
.s
-1
x 10
6
) (Mean ± SD) (mL.g
-1
.s
-1
x 10
6
)
Variability Cortex Striatum Hippocampus Cortex Striatum Hippocampus
Group (n)
Normothermia (8) 30.6 ± 9.1 5.2 ± 3.0 2.0 ± 0.5 1.2 ± 0.2 1.1 ± 0.3 1.5 ± 0.3
Hypothermia (7) 23.1 ± 9.1 4.0 ± 1.5 1.9 ± 0.7 1.3 ± 0.4 1.1 ± 0.5 1.6 ± 0.7
32-33ºC
Normothermia (7) 34.7 ± 10.9 5.0 ± 1.3 2.7 ± 1.2 2.0 ± 0.4 1.0 ± 1.0 2.3 ± 1.0
Hypothermia (7) 15.4 ± 8.8** 3.7 ± 1.7 1.8 ± 0.7 1.5 ± 0.2 1.2 ± 0.3 1.8 ± 0.4
28-29ºC
** p<0.01, student t-test.
Figure 1: Biphasic opening of the blood-brain barrier in right cerebral cortex of the rat after 2 hours of occlusion and 46 hours of reperfusion of the
right MCA. Opening of BBB indicated by increased transfer constant K
i
for blood-to-brain diffusion of
3
H-sucrose. The K
i
values for the right cortex
(ipsilateral to the MCA occlusion) and left cortex from individual animals are represented by open and shaded circles, respectively. The open square
with error bars represent the mean ±SD for each time period. ** p<0.01; *** p<0.001, significantly elevated from control values.
Post-ischemic hypothermia (28
o
C - 29
o
C) for the first 6 hours
had no ameliorative effect upon the edema measured in the
cortex 46 hours after reperfusion. The mean ( ± SD) percentage
water (ml.g
-1
x 100) for the normothermic group was 86.1 ±
0.7% for the post-ischemic right cortex and 79.8 ± 0.7% for the
contralateral left cortex, versus 85.7 ± 1.4% (right) and 79.6 ±
0.3% (left) for that of the hypothermic group.
Experiment 4
Despite the failure of moderate post-ischemic hypothermia to
reduce the accumulation of edema in hypothermia (28
o
C - 29
o
C)
for the first 6 hours of the 46 hour reperfusion period, this resulted
in a mean cortical infarct volume of 122 ± 57 mm
3
(n = 6) (Figure
2), which was significantly lower than that of the normothermic
control group (175 ± 22 mm
3
, n = 6) (p < 0.05) (Table 4). (Table
4). Animals receiving 6 hours of mild hypothermic reperfusion
(32
o
C - 33
o
C) had a total infarct volume of 149 ± 39 mm
3
(n = 6)
at 46 hours, which was less than that of the control group, but not
significantly so. The reduction in the size of injury relates to
smaller volumes of infarction rather than differences in the
amount of swelling or edema, confirming Experiment 3.
D
ISCUSSION
In these transient ischemic experiments, the widest BBB
openings and increases in K
i
were seen in the post-ischemic right
cerebral cortex, which was dissected to include both the core and
edge of the region perfused by the MCA. The opening was
clearly biphasic, characterized by an initial 10-fold augmentation
in K
i
during the first half hour of reperfusion, followed by partial
closing, and then a delayed, but progressive, opening between 22
and 46 hours post-reperfusion. Moderate hypothermia during
ischemia dramatically reduced infarction and edema, as well as
preventing BBB opening, but also had partial effects on infarct
size when instituted during the post-ischemic period following
normothermic ischemia.
11
In these studies, we have
demonstrated that postischemic moderate hypothermia affects
not only the size of the infarct, it does so in tandem with
reductions in the opening of the BBB, not by simply reducing the
amount of vasogenic edema, but possibly by interfering with the
post-ischemic inflammatory response.
This profile of BBB injury shows similarities to findings based
on the assessment of Evan’s Blue dye extravasation in the cat.
13
Following one hour of temporary MCA occlusion, dye injected i.v.
early in reperfusion caused staining of brain parenchyma. This was
followed by a refractory period, and then a delayed opening, which
was visible in cats sacrificed five hours or three days post-stroke.
The initial acute opening has been described as a ‘hemodynamic’
BBB opening.
4,13
Because of acidosis, loss of autoregulation, and
vasodilation of the cerebral vasculature, reperfusion results in
excessive blood flow or ‘luxury perfusion’. High intraluminal
blood pressure in the cerebral microvasculature has been shown to
induce abnormal pinocytotic transport across endothelial cells, and
opening of interendothelial tight junctions.
14,15
A significant role of
arterial pressure in the degree of post-reperfusion opening after
Table 3: Percentage of Water in MCA Model (Experiment 3)
Variability Right Cortex Left Cortex
Group (n) % of Water (Mean ± SD) % of Water (Mean ± SD)
Normothermia
4 hours post-reperfusion (5) 80.4 ± 0.3
a
78.5 ± 0.2
22 hours post-reperfusion (5) 83.7 ± 0.6
ab
78.8 ± 0.1
46 hours post-reperfusion (6) 86.1 ± 0.7
ab
79.8 ± 0.7
Moderate Hypothermia (6) 85.7 ± 1.4
ab
79.6 ± 0.3
p < 0.01 for ANOVA plus Tukey’s test.
a – right side values different from corresponding left side values; b – different from 4 hr post-reperfusion value.
Figure 2: Volume of neocortical infarction for each rat following 2
hours of normothermic transient MCA occlusion and 46 hours of
reperfusion, in the first 6 hours of which animals were maintained at
either 37
o
C-38
o
C (normothermia), 32
o
C-33
o
C (mild hypothermia), or
28
o
C-29
o
C (moderate hypothermia). The mean edema and infarct sizes
are displayed ±SD (the asterisk denotes significantly less injury
(p<0.05). The n value for each group is indicated in brackets.
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
302
MCAO has been demonstrated.
16
After 3 hours of MCAO and 30
min re-circulation, BBB opening to Evan’s Blue dye was greatly
augmented in rats that had been rendered hypertensive with
phenylephrine during the reperfusion period. The magnitude of
acute hyperemic BBB opening, and of modulating factors, such as
blood pressure, would appear to be an important consideration in
utilizing and interpreting the MCAO model. For example, factors
such as hypertension, which augment post-reperfusion opening,
and the ensuing homeostatic changes might thereby indirectly
influence subsequent neuropathological events. On the other hand,
one might anticipate that the degree of early post-ischemic BBB
opening could have a positive impact on the efficacy of
experimental drugs when the chemical nature of these compounds
limits their ability to cross the normal BBB. For instance, with the
competitive AMPA antagonist NBQX, which penetrates the blood-
brain barrier, effective concentrations of the drug are achieved
following transient focal ischemia, perhaps as a consequence of
the opening of the barrier at the time the drug is circulating.
17
In this study, partial recovery from the acute opening of the
BBB was evidenced by the fact that K
i
values at one or four
hours post-reperfusion were significantly lower than those
measured acutely, but were higher than baseline values, or values
for contralateral non-ischemic cortex. The second part of the
biphasic opening was then indicated by the significant elevation
of K
i
at 22 hours post-reperfusion as compared to that at four
hours, with an even more dramatic upward increment taking
place between 22 and 46 hours. Accounting for this time delay
would seem important in any proposal on the cause(s) of BBB
opening, which presumably differs from that underlying the
acute post-ischemic opening. In fact, the delayed BBB opening
to
3
H-sucrose is consistent with the published observations that
between 24 and 48 hours after transient MCAO, there occurs a
rapid evolution of delayed edema, which peaks within this time
period, and that infiltration of polymorphonuclear cells follows a
similar time course.
18
Vascular endothelial leakiness was
proposed to result from the release of lipid inflammatory
mediators through the interaction of injured tissue with
infiltrating leukocytes and aggregating platelets.
19
Among the
possible mediators of BBB dysfunction and formation of
vasogenic edema, proteases, bradykinin, histamine, and
eicosanoid products of arachidonic acid metabolism and free
radicals have been strongly implicated.
20
It is well documented that neuronal injury is reduced by
induction of hypothermia during ischemia, or even by its
induction during the post-ischemic reperfusion period.
21
The
experiments in the present study quantitate for the first time a
protective effect of post-ischemic hypothermia on the delayed
BBB injury that follows temporary MCAO. Mean K
i
values after
46 hours of reperfusion were more than 50% lower in rats that
underwent cooling to 29
o
C for 6 hours. Although a light degree
of halothane anesthesia in the cooled rats may have contributed
a protective effect, efficacy of lowered brain temperature per se
was suggested by the fact that 28
o
C - 29
o
C was more protective
than 32
o
C - 33
o
C. Separate experiments showed, however, that
the 6 hours of hypothermic treatment at 28
o
C - 29
o
C did not
reduce the amount of edema present at 46 hours post-reperfusion,
even though this treatment appeared to favourably affect both
BBB damage and infarct volume.
Post-ischemic hypothermic protective mechanisms may be
related to a slight attenuation in the reperfusion hyperemia.
During reperfusion, hypothermia may reduce leukotrienes,
22
improve glucose utilization and blood flow,
23
and slow free
radical reactions and the propagation of lipid peroxidation
cascades. This could prevent the leakage of proteins and the
accumulation of extracellular fluid
24
and inhibit the biosynthesis,
release and uptake of neurotransmitters, such as glutamate and
dopamine.
25
There are two massive glutamate release points in
the first 4 hour period of reperfusion following MCA/CCA
occlusion.
26
The quantal release of glutamate has been recently
correlated with the size of neocortical infarction in focal
ischemia
27
and may result in endothelial cell damage in the BBB.
The blockade on the non-NMDA glutamate receptors attenuates
brain damage.
17
Therefore, any reduction of glutamate
concentration in the extracellular space by delayed hypothermia
may protect against brain damage.
In conclusion, following transient focal ischemia,
measurements of K
i
for BBB permeation of
3
H-sucrose have
demonstrated both an acute opening, likely hemodynamic in
nature, and a delayed opening of the ipsilateral cortex MCAO.
Clearly, hypothermia has potent effects on BBB opening
28
and
does reduce infarct size, but through mechanisms other than
reducing edema. The quantitative power of K
i
measurements
should facilitate the exploration of drug or other treatments to
offset the disadvantages of reperfusion therapy (BBB opening
and edema) and facilitate its benefits. The understanding of the
interplay between microvascular damage, edema, inflammation,
and neuronal death hours after thromboembolic stroke is critical
to the development of successful stroke therapies.
Table 4 : Effects of infarct volume and edema formation following post-ischemic hypothermia in MCA Model (Experiment 4)
Variability Edema Infarction Total Infarct Volume
Group (n) (mm
3
) (Mean ± SD) (mm
3
) (Mean ± SD) (mm
3
) (Mean ± SD)
Normothermia (6) 58 ± 17 117 ± 13 175 ± 23
Mild Hypothermia (6) 67 ± 23 83 ± 31* 149 ± 39
Moderate Hypothermia (6) 43 ± 26 79 ± 33* 122 ± 57
* p< 0.05, between treatments for ANOVA test.
Volume 26, No. 4 – November 1999
303
LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES
ACKNOWLEDGEMENTS:
Supported, in part, by grants from the Heart and Stroke Foundation of
Canada. Alastair Buchan is a Senior Scholar of the Alberta Heritage
Medical Research Foundation.
REFERENCES
1. Rapoport SI. Sites and function of the blood-brain barrier. In:
Rapoport SI, ed. Blood-Brain Barrier in Physiology and
Medicine. New York: Raven Press, 1976: 43-86.
2. Betz AL. Oxygen free radicals and the brain microvasculature. In:
Pardridge WM, ed. The Blood-Brain Barrier. Cellular and
Molecular Biology. New York: Raven Press, 1993: 303-321.
3. Betz AL, Keep RF, Beer ME, Ren X-d. Blood-brain barrier
permeability and brain content of sodium, potassium and chloride
during focal ischemia. J Cereb Blood Flow Metab 1994; 14: 29-
37.
4. Klatzo I. Concept of ischemic injury associated with brain edema.
In: Inaba Y, Klatzo I, Spatz M, eds. Brain Edema. Tokyo:
Springer, 1984: 1-5.
5. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal
brain ischemia in the rat: methods for reproducible neocortical
infarction using tandem occlusion of the distal middle cerebral
and ipsilateral common carotid arteries. J Cereb Blood Flow
Metab 1988; 8: 474-485.
6. Buchan AM, Xue D, Slivka A. A new model of temporary focal
neocortical ischemia in the rat. Stroke 1992; 23: 273-279.
7. Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang X-J, Pulsinelli W.
Temporal thresholds for neocortical infarction in rats subjected to
reversible focal cerebral ischemia. Stroke 1991; 22: 1032-1039.
8. Preston E, Allen M, Haas N. A modified method for measurement of
radiotracer permeation across the rat blood-brain barrier: the
problem of correcting brain uptake for intravascular tracer. J
Neurosci Meth 1983; 9:45-55.
9. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of
cerebrovascular permeability to nonelectrocytes in the conscious
rat. Am J Physiol 1978; 235: H299-H307.
10. Preston E, Haas N. Defining the lower limits of blood-brain barrier
permeability: factors affecting the magnitude and interpretation
of permeability-area products. J Neurosci Res 1986; 6: 709-716.
11. Xue D, Huang ZG, Smith KE, Buchan AM. Immediate or delayed
mild hypothermia prevents focal cerebral infarction. Brain Res
1992; 587: 66-72.
12. Ishimaru S, Hossman KA. Relationship between cerebral blood
flow and blood-brain barrier permeability of sodium and albumin
in cerebral infarcts of rats. Acta Neurochir 1990; 51(S): 216-219.
13. Kuroiwa T, Ting P, Klatzo I. The biphasic opening of the blood-
brain barrier to proteins following temporary middle cerebral
artery occlusion. Acta Neuropathol 1985; 68: 122-129.
14. Westergaard E, van Deurs B, Brondsted HE. Increased vesicular
transfer of horseradish peroxidase across cerebral endothelium,
evoked by acute hypertension. Acta Neuropathol 1977; 37: 141-152.
15. Nagy Z, Mathieson G, Huttner I. Blood-brain barrier opening to
horseradish peroxidase in acute arterial hypertension. Acta
Neuropathol 1979; 48: 45-53.
16. Cole DJ, Matsumura JS, Drummond JC, Schultz RL, Wong MH.
Time- and pressure-dependent changes in blood-brain barrier
permeability after temporary middle cerebral artery occlusion in
rats. Acta Neuropathol 1991; 82: 266-273.
17. Buchan AM, Xue D, Huang ZG, Smith KE, Lesiuk H. Delayed
AMPA receptor blockade reduces cerebral infarction induced by
focal ischemia. NeuroReport 1991; 2: 473-476.
18. Hsu CY, Liu TH, Xu J, et al. Arachodonic acid and its metabolites
in cerebral ischemia. Ann NY Acad Sci 1989; 559: 282-295.
19. Hsu CY, Liu TH, Xu J, Hogan EL, Chao J. Lipid inflammatory
mediators in ischemic brain edema and injury. In: Bazan NG ed.
Lipid Inflammatory Mediators in Ischemic Brain Damage and
Experimental Epilepsy. New Trends Lipid Mediators Research.
Basel: Karger, 1990: 85-112.
20. Wahl M, Unterberg A, Baethmann A, Schilling L. Mediators of
blood-brain barrier dysfunction and formation of vasogenic brain
edema. J Cereb Blood Flow Metab 1988; 8: 621-634.
21. Ginsberg MD, Sternau LL, Globus MYT, Dietrich WD, Busto R.
Therapeutic modulation of brain temperature: relevance to
ischemic brain injury. Cerebrovasc Brain Metab Rev 1992; 4:
189-225.
22. Dempsey RJ, Combs DJ, Edwards MM. Moderate hypothermia
reduces post-ischemic edema development and leukotriene
production. Surgery 1987; 21: 177-181.
23. Busto R, Dietrich WD, Globus MY, Ginsberg MD. Postischemic
hypothermia inhibits CA1 hippocampal ischemic neuronal injury.
Neurosci Lett 1989a; 101: 299-304.
24. Dietrich WD, Halley M, Valdes I, Busto R. Interrelationship
between increased vascular permeability and acute neuronal
damage following temperature controlled brain ischemia in rats.
Acta Neuropathol 1991; 81: 615-625.
25. Busto R, Globus MYT, Dietrich WD, et al. Effects of mild
hypothermia on ischemia-induced release of neurotransmitter and
free fatty acids in rat brain. Stroke 1989b; 20: 904-910.
26. Osuga H, Hakim AM. The changes in extracellular glutamate
concentration during focal ischemia in rat. Can J Neurol Sci
1992; 19: 301-302.
27. Butcher SP, Bullock R, Graham DI, McCulloch J. Correlation
between amino acid release and neuropathologic outcome in rat
brain following middle cerebral artery occlusion. Stroke 1990;
21: 1727-1733.
28. Preston E, Sutherland G, Finsten A. Three openings of the blood-
brain barrier produced by forebrain ischemia in the rat. Neurosci
Lett 1992; 149: 75-78.
304
THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
... In neurological diseases such as stroke [122][123][124][125][126], traumatic brain injury [127,128] and Alzheimer's disease [129], as well as in some neurological infections [130], BBB disruption has been demonstrated to be biphasic in nature. For example, experimental studies in ischaemic stroke have provided extensive evidence that demonstrates an early opening of the BBB within the first 4-6 h of a stroke is followed by a refractory period and then a late opening ∼48-72 h [131,132]. However, there is also evidence to suggest BBB recovery is not complete following the initial opening, and that BBB continues to be leaky [133,134]. ...
Article
Full-text available
A healthy brain is protected by the blood-brain barrier (BBB), which is formed by the endothelial cells that line brain capillaries. The BBB plays an extremely important role in supporting normal neuronal function by maintaining the homeostasis of the brain microenvironment and restricting pathogen and toxin entry to the brain. Dysfunction of this highly complex and regulated structure can be life threatening. BBB dysfunction is implicated in many neurological diseases such as stroke, Alzheimer's disease, multiple sclerosis, and brain infections. Among other mechanisms, inflammation and/or flow disturbances are major causes of BBB dysfunction in neurological infections and diseases. In particular, in ischaemic stroke, both inflammation and flow disturbances contribute to BBB disruption, leading to devastating consequences. While a transient or minor disruption to the barrier function could be tolerated, chronic or a total breach of the barrier can result in irreversible brain damage. It is worth noting that timing and extent of BBB disruption play an important role in the process of any repair of brain damage and treatment strategies. This review evaluates and summarises some of the latest research on the role of the BBB during neurological disease and infection with a focus on the effects of inflammation and flow disturbances on the BBB. The BBB's crucial role in protecting the brain is also the bottleneck in central nervous system drug development. Therefore, innovative strategies to carry therapeutics across the BBB and novel models to screen drugs, and to study the complex, overlapping mechanisms of BBB disruption are urgently needed.
... The BBB breakdown after an ischemic insult is a dynamic process. Animal models of focal ischemia have shown that BBB breakdown may follow a biphasic course after reperfusion (Belayev et al. 1996;Huang et al. 1999;Jiang et al. 2018). An early (~ 6 h) increase in permeability is followed by a refractory period during which BBB permeability returns to baseline and a delayed second increase in permeability (Carmichael 2016;Bernardo-Castro et al. 2020). ...
Article
Full-text available
Phosphodiesterase 4 inhibitors (PDE4-I), which selectively increase cyclic adenosine monophosphate (cAMP) levels, have shown neuroprotective effects after several neurological injuries inducing blood-brain barrier (BBB) damage including local/focal cerebral ischemia. The present investigated whether roflumilast confers BBB neuroprotection in the hippocampus after transient global cerebral ischemia (TGCI) in rats. TGCI resulted in whole BBB disruption as measured by the increase of Evans blue (EB) and IgG extravasation, neurodegeneration, and downregulation of claudin-5 and endothelial nitric oxide synthase (eNOS) levels in the CA1 hippocampal subfield of ischemic rats. Roflumilast attenuated BBB disruption and restored the levels of eNOS in the CA1 hippocampal area. Moreover, roflumilast increased the levels of B2 cell lymphoma (BcL-2) and neuron-glial antigen-2 (NG2) in the CA1 subfield after global ischemia in rats. The protective effects of roflumilast against TGCI-induced BBB breakdown might involve preservation of BBB integrity, vascularization and angiogenesis, and myelin repair.
... Increased BBB permeability is an initial event and central feature of multiple sclerosis (MS) [83][84][85]. BBB dysfunction is also observed in ischemic strokes, in which leukocytes infiltrate into the lesion site through leaky blood vessels and induce pathological inflammation after the stroke onset [86,87]. Epileptic patients also demonstrate BBB leakage; however, the precise role of BBB dysfunction in the pathogenesis of epilepsy remains obscure [88][89][90]. ...
Article
Full-text available
Excessive intake of ethanol is associated with severe brain dysfunction, and the subsequent neurological and behavioral abnormalities are well-established social risks. Many research studies have addressed how ethanol induces neurological toxicity. However, the underlying mechanisms with which ethanol induces neurological toxicity are still obscure, perhaps due to the variety and complexity of these mechanisms. Epithelial cells are in direct contact with blood and can thus mediate ethanol neurotoxicity. Ethanol activates the endothelial cells of blood vessels, as well as lymphatic vessels, in a concentration-dependent manner. Among various signaling mediators, nitric oxide plays important roles in response to ethanol. Endothelial and inducible nitric oxide synthases (eNOS and iNOS) are upregulated and activated by ethanol and enhance neuroinflammation. On the other hand, angiogenesis and blood vessel remodeling are both affected by ethanol intake, altering blood supply and releasing angiocrine factors to regulate neuronal functions. Thus, ethanol directly acts on endothelial cells, yet the molecular target(s) on endothelial cells remain unknown. Previous studies on neurons and glial cells have validated the potential contribution of membrane lipids and some specific proteins as ethanol targets, which may also be the case in endothelial cells. Future studies, based on current knowledge, will allow for a greater understanding of the contribution and underlying mechanisms of endothelial cells in ethanol-induced neurological toxicity, protecting neurological health against ethanol toxicity.
... It is notable we observed a lower magnitude second BBB opening at approximately 6 h after LiFU, evidenced by higher penetration of 14 C-AIB and TX Red in brain. The phenomenon of biphasic BBB opening has previously been reported in several conditions where BBB integrity is damaged including stroke, transient focal ischemia, or traumatic brain injury [52][53][54]. While an exact reason for this phenomenon is unknown, it is hypothesized primary BBB breakdown leads to activation of secondary neuroinflammatory pathways which can cause the barrier to be more leaky [37]. ...
Article
Full-text available
Background Systemic drug delivery to the central nervous system is limited by presence of the blood–brain barrier (BBB). Low intensity focused ultrasound (LiFUS) is a non-invasive technique to disrupt the BBB, though there is a lack of understanding of the relationship between LiFUS parameters, such as cavitation dose, time of sonication, microbubble dose, and the time course and magnitude of BBB disruption. Discrepancies in these data arise from experimentation with modified, clinically untranslatable transducers and inconsistent parameters for sonication. In this report, we characterize microbubble and cavitation doses as LiFUS variables as they pertain to the time course and size of BBB opening with a clinical Insightec FUS system. Methods Female Nu/Nu athymic mice were exposed to LiFUS using the ExAblate Neuro system (v7.4, Insightec, Haifa, Israel) following target verification with magnetic resonance imaging (MRI). Microbubble and cavitation doses ranged from 4–400 μL/kg, and 0.1–1.5 cavitation dose, respectively. The time course and magnitude of BBB opening was evaluated using fluorescent tracers, ranging in size from 105–10,000 Da, administered intravenously at different times pre- or post-LiFUS. Quantitative autoradiography and fluorescence microscopy were used to quantify tracer accumulation in brain. Results We observed a microbubble and cavitation dose dependent increase in tracer uptake within brain after LiFUS. Tracer accumulation was size dependent, with ¹⁴ C-AIB (100 Da) accumulating to a greater degree than larger markers (~ 625 Da–10 kDa). Our data suggest opening of the BBB via LiFUS is time dependent and biphasic. Accumulation of solutes was highest when administered prior to LiFUS mediated disruption (2–fivefold increases), but was also significantly elevated at 6 h post treatment for both ¹⁴ C-AIB and Texas Red. Conclusion The magnitude of LiFUS mediated BBB opening correlates with concentration of microbubbles, cavitation dose as well as time of tracer administration post-sonication. These data help define the window of maximal BBB opening and applicable sonication parameters on a clinically translatable and commercially available FUS system that can be used to improve passive permeability and accumulation of therapeutics targeting the brain.
Article
Full-text available
Oedema occurs when higher than normal amounts of solutes and water accumulate in tissues. In brain parenchymal tissue, vasogenic oedema arises from changes in blood–brain barrier permeability, e.g. in peritumoral oedema. Cytotoxic oedema arises from excess accumulation of solutes within cells, e.g. ischaemic oedema following stroke. This type of oedema is initiated when blood flow in the affected core region falls sufficiently to deprive brain cells of the ATP needed to maintain ion gradients. As a consequence, there is: depolarization of neurons; neural uptake of Na⁺ and Cl⁻ and loss of K⁺; neuronal swelling; astrocytic uptake of Na⁺, K⁺ and anions; swelling of astrocytes; and reduction in ISF volume by fluid uptake into neurons and astrocytes. There is increased parenchymal solute content due to metabolic osmolyte production and solute influx from CSF and blood. The greatly increased [K⁺]isf triggers spreading depolarizations into the surrounding penumbra increasing metabolic load leading to increased size of the ischaemic core. Water enters the parenchyma primarily from blood, some passing into astrocyte endfeet via AQP4. In the medium term, e.g. after three hours, NaCl permeability and swelling rate increase with partial opening of tight junctions between blood–brain barrier endothelial cells and opening of SUR1-TPRM4 channels. Swelling is then driven by a Donnan-like effect. Longer term, there is gross failure of the blood–brain barrier. Oedema resolution is slower than its formation. Fluids without colloid, e.g. infused mock CSF, can be reabsorbed across the blood–brain barrier by a Starling-like mechanism whereas infused serum with its colloids must be removed by even slower extravascular means. Large scale oedema can increase intracranial pressure (ICP) sufficiently to cause fatal brain herniation. The potentially lethal increase in ICP can be avoided by craniectomy or by aspiration of the osmotically active infarcted region. However, the only satisfactory treatment resulting in retention of function is restoration of blood flow, providing this can be achieved relatively quickly. One important objective of current research is to find treatments that increase the time during which reperfusion is successful. Questions still to be resolved are discussed.
Preprint
Full-text available
Ischaemic stroke treatment is limited to recanalizing the occluded vessel, while there is no approved adjunctive cerebroprotective therapy to protect either the neurons and parenchyma or the neurovascular unit. Pharmacological inhibition of mammalian target of rapamycin-1 (mTORC1) with rapamycin has shown promise in reducing infarct volume and improving functional outcomes. However, previous studies that investigated the effects of rapamycin on the vasculature and cerebral blood flow (CBF), administered rapamycin prior to or during stroke induction, thus limiting the potential for clinical translation. Therefore we investigated whether rapamycin maintains its cerebrovascular protective effect when administered immediately after recanalization following 90 minutes stroke in Wistar rats. We show, that rapamycin significantly improved post-recanalization cerebral blood flow (CBF), suggesting a beneficial neurovascular effect of rapamycin. Rats treated with rapamycin had smaller infarct volumes and improved functional outcomes compared to the control animals at three days post-stroke. The mechanisms of the overall positive effects seen in this study are likely due to rapamycins hyperacute effects on the neurovasculature, as shown with increased CBF during this phase. This paper shows that rapamycin treatment is a promising adjunct cerebroprotective therapy option for ischemic stroke.
Article
Endothelial integrity is critical in mitigating a vicious cascade of secondary injuries following acute ischemic stroke (AIS). Matrix metalloproteinase-9 (MMP-9), a contributor to endothelial integrity loss, is elevated during stroke and is associated with worsened stroke outcome. We investigated the FDA approved selective sphingosine-1-phosphate receptor 1 (S1PR1) ligand, ozanimod, on the regulation/activity of MMP-9 as well as endothelial barrier components (PECAM-1, claudin-5, and ZO-1) in human brain microvascular endothelial cells (HBMECs) following hypoxia plus glucose deprivation (HGD). We previously reported that S1PR1 activation improves HBMEC integrity; however, mechanisms underlying S1PR1 involvement in endothelial cell barrier integrity have not been clearly elucidated. We hypothesized that ozanimod would attenuate an HGD-induced increase in MMP-9 activity which would concomitantly attenuate the loss of integral barrier components. Male HBMECs were treated with ozanimod or vehicle and exposed to 3h of normoxia (21% O2) or HGD (1% O2). Immunoblotting, zymography, qRT-PCR, and immunocytochemical labeling techniques assessed processes related to MMP-9 and barrier markers. We observed that HGD acutely increased MMP-9 activity and reduced claudin-5 and PECAM-1 levels, and ozanimod attenuated these responses. In situ analysis via PROSPER, suggested that attenuation of MMP-9 activity may be a primary factor in maintaining these integral barrier proteins. We also observed that HGD increased intracellular mechanisms associated with augmented MMP-9 activation, however ozanimod had no effect on these select factors. Thus, we conclude that ozanimod has the potential to attenuate HGD mediated decreases in HBMEC integrity in part by decreasing MMP-9 activity as well as preserving barrier properties.
Article
Background: Blood-brain barrier permeability (BBBp) is key process involved in ischemic stroke pathophysiology. However, there is a lack of consensus on how BBBp evolves after the ischaemic injury, and its clinical relevance at different time points post stroke. Aims: To assess BBBp evolution through stroke phases, and its implications on patient outcomes. Methods: We screened PubMed/MEDLINE, EMBASE, Web of Science, Scopus and Cochrane Central Register of Controlled Trials up to December 31, 2021. We included research quantitatively using neuroimaging to assess BBBp in stroke patients. BBBp in the different phases was evaluated by a random effect model based on the standardized mean difference (SMD) between the ipsilateral and contralateral sides of the brain. We performed subgroup analysis on clinical outcome, reperfusion treatment, haemorrhagic transformation and imaging method. Results: We identified 3761 studies of which 22 (1592 patients, 1787 evaluations) were included in our study. Overall, 17 studies reported BBBp for the hyperacute phase, eight for the acute, five for the subacute and two for the chronic phase. All phases were associated with increased BBBp : 0.74 (0.48-0.99), 1.68 (0.94-2.42), 1.98 (0.96-3.00) and 1.00 (0.45-1.55) respectively. An increase in BBBp was associated with hemorrhagic transformation in the hyperacute phase, and with improved functional outcomes in the late subacute phase. Conclusions: BBBp is persistently increased after stroke, peaking in the acute and subacute phases. The degree of BBBp influences patient outcomes depending on stroke phase. Our findings support the clinical relevance of BBBp dynamics in stroke care.
Article
Ischemic stroke, as a prevalent neurological disorder, often results in rapid increases in the production of reactive oxygen species (ROS) and inflammatory factors in the focal ischemic area. Though edaravone is an approved treatment, its effect is limited due to its weak ability to cross the blood-brain barrier (BBB) and short half-life. Other effective pharmacological treatment options are clearly lacking. In this study, PNIVDBrF-3-Eda (also named MG-3-Eda) was prepared using a thermo- and pH dual-responsive PNIVDBrF microgel. These were designed with a positively charged network, as synthesized by simultaneous quaternization cross-linking and surfactant-free emulsion copolymerization, to be loaded with the negatively charged edaravone. We then investigated whether such a targeted delivery of edaravone could provide enhanced neuroprotection. Cytotoxicity assays confirmed that the microgel (<1 mg/mL) exhibited promising cytocompatibility with no remarkable effect on cell viability, cell cycle regulation, or apoptosis levels. In vitro and in vivo experiments demonstrated that the microgels could successfully penetrate the blood-brain barrier where efficient BBB crossing was observed after disruption of the BBB due to ischemic injury. This enabled MG-3-Eda to target the cerebral ischemic area and achieve local release of edaravone. Treatment with MG-3-Eda significantly reduced the cerebral infarct area in transient middle cerebral artery occlusion (tMCAO) mice and significantly improved behavioral scores. MG-3-Eda treatment also prevented the reduction in NF200 expression, a neuronal marker protein, and attenuated microglia activation (as detected by Iba1) in the local ischemic area via local antioxidant and anti-inflammatory effects. A superior neuroprotective effect was noted for MG-3-Eda compared to that for free edaravone. Our results indicate that MG-3-Eda administration represents a clear potential treatment for cerebral ischemia via its targeted delivery of edaravone to ischemic areas where it provides significant local antioxidant and anti-inflammatory effects.
Article
Ischaemic stroke is a leading cause of disability and death for which no acute treatments exist beyond recanalization. The development of novel therapies has been repeatedly hindered by translational failures that have changed the way we think about tissue damage after stroke. What was initially a neuron-centric view has been replaced with the concept of the neurovascular unit (NVU), which encompasses neuronal, glial and vascular compartments, and the biphasic nature of neural-glial-vascular signalling. However, it is now clear that the brain is not the private niche it was traditionally thought to be and that the NVU interacts bidirectionally with systemic biology, such as systemic metabolism, the peripheral immune system and the gut microbiota. Furthermore, these interactions are profoundly modified by internal and external factors, such as ageing, temperature and day-night cycles. In this Review, we propose an extension of the concept of the NVU to include its dynamic interactions with systemic biology. We anticipate that this integrated view will lead to the identification of novel mechanisms of stroke pathophysiology, potentially explain previous translational failures, and improve stroke care by identifying new biomarkers of and treatment targets in stroke.
Chapter
During investigations of the complex pathophysiology of cerebral ischemia, several concepts determining some patterns of ischemic injury have been increasingly recognized. These are: (a) selective vulnerability with patterns of selective damage to various neuronal units following an ischemic insult; (b) thresholds with regard to various parameters of ischemic injury; (c) the maturation phenomenon, i.e., progressive development of the lesions following an ischemic insult, and related to it; and (d) peripheral expansion of the necrotic core of an infarction into the adjacent areas of penumbra. This last may lead to (e) a vicious circle — a synergistic, reciprocal relationship between regional increase in tissue pressure due to necrosis and edema and reduction of the regional cerebral blood flow (rCBF) to below critical levels for survival of the tissue in the adjacent areas.
Article
Acute arterial hypertension was induced in male Wistar rats using two experimental techniques: (1) i.v. injection of Aramine and (2) infusion of physiological saline as a bolus via internal carotid artery. Horseradish peroxidase (HRP) was injected i.v. prior to both experimental procedures and subsequently localized in the brain by light and electron microscopy. In the saline infusion (pressure pulse) model, colloidal lanthanum was also applied as a diffusion tracer following fixation of the cerebral endothelium. In the Aramine model, extravasation of HRP correlated with abrupt elevation of blood pressure. In the pressure pulse model HRP extravasation was consistently visualized in the affected hemisphere. Electron microscopy showed consistent labeling of plasmalemmal vesicles by HRP in segments of cerebral endothelium. However, HRP was also clearly visualized in junctional pools suggesting focal opening of endothelial tight junctions as a pathway for extravasation of this tracer in both hypertensive models. Colloidal lanthanum not transported by plasmalemmal vesicles across endothelium after fixation of the brain also bypassed consecutive membrane appositions of endothelial tight junctions indicating existance of interendothelial pathways to macromolecules in acute arterial hypertension.
Article
Vascular permeability P in different cerebral regions of the conscious rat was determined, independently of blood flow, for 14C tracers of glycerol, mannitol, sucrose, and inulin. A tracer was injected intravenously, arterial plasma concentrations were monitored, and regional brain concentrations were measured at specific times thereafter. A plasma-brain two-compartment model was used to calculate mean regional values of P, letting capillary area equal 240 cm2xg-1. P was 2-4x10-6 cm/s-1 for glycerol, 0.95-1.4x10-7 for mannitol, 2.5-3.0x10-8 for sucrose, and 1.0-1.4x10-9 for inulin. Cerebrovascular permeability coefficients correspond to coefficients at single cell membranes and lipid bilayers, but are 1,000 times less than at muscle capillaries. The relation between cerebrovascular permeability and octanol/water partition suggests that saccharides diffuse into the brain through homogeneous endothelial cell membranes and not through capillary pores or by means of vesicles. Estimated cerebral distribution volumes for the tracers indicate that glycerol distributes rapidly within the brain extracellular and intracellular compartments and may be incoporated into the metabolic pool, that mannitol distributes extracellularly and partially intracellularly, and that sucrose remains within the extracellular space.
Article
Acute hypertension in rats was produced by intravenous infusion of metaraminol bitartrate (Aramine). The permeability to intravenously injected horseradish peroxidase (HRP) was increased across the cerebral arterioles, capillaries and venules. From the basement membranes of the vessel walls the protein tracer moved into the extracellular spaces of the adjacent neuropil. No endothelial cell damage was observed. The tight junctions between endothelial cells were intact and prevented intercellular movement of peroxidase. Many HRP-labeled vesicles within the endothelial cells or connected with the luminal or abluminal surface, occurred in segments of the microvasculature. Otherwise the endothelium was unchanged. Diffuse uptake of HRP into the cytoplasm of neurons and glial cells was not observed. The alphablocker phentolamine (Regitin) was given to a group of rats simultaneously to Aramine. The increase in blood pressure was thus prevented; furthermore, the permeability remained as under normal conditions. The Aramine, Regitin and HRP did not significantly influence the pH,pO2 andpCO2 of the arterial blood. It is concluded that acute hypertension increases the vesicular transport of HRP across the endothelium of cerebral arterioles, venules and capillaries that normally occurs to a small extent only after intravenous injection of the tracer.
Article
Hypothermia was first applied therapeutically as a local anesthetic and later was used to achieve organ protection during procedures necessitating circulatory interruption. Profound whole-body hypothermia, typically carried out in conjunction with extracorporeal bypass, has long been employed during cardiac and neurosurgical operative procedures. More recently, studies in small-animal experimental models of cerebral ischemia have provided persuasive evidence that even small decreases in brain temperature confer striking protection against ischemic neuronal injury. By contrast, small elevations of brain temperature during ischemia accelerate and extend pathologic changes in the brain and promote early disruption of the blood-brain barrier. Hypothermia retards the rate of high-energy phosphate depletion during ischemia and promotes postischemic metabolic recovery. More importantly, mild intraischemic hypothermia markedly attenuates the release of glutamate into the brain's extracellular space and significantly diminishes the release of dopamine. Similarly, the inhibition of calcium-calmodulin-dependent protein kinase II triggered by normothermic ischemia is prevented by hypothermia, as is the ischemia-induced translocation and inhibition of the key regulatory enzyme protein kinase C. Hypothermia also appears to facilitate the resynthesis of ubiquitin following ischemia. Studies of potential clinical importance have shown that moderate hypothermia is capable of attenuating ischemic damage even if instituted early in the postischemic period. In the setting of focal cerebral ischemia, moderate brain hypothermia reduces the infarct size (particularly in the setting of reversible middle cerebral artery occlusion); conversely, hyperthermia markedly increases the infarct volume. These studies underscore the importance of monitoring and regulating the brain temperature during experimental studies of cerebral ischemia to insure a consistent pathologic outcome and to avoid the false attribution of "pharmacoprotection" to drugs that reduce the body temperature. The measurement of brain temperature is now practicable in neurosurgical patients requiring invasive monitoring, and human studies have shown that cortical and cerebroventricular temperatures may exceed systemic temperatures. Mild to moderate decreases in brain temperature are neuroprotective in cerebral ischemia, while mild elevations of brain temperature are markedly deleterious in the setting of ischemia or injury. It is anticipated that controlled clinical trials of therapeutic brain temperature modulation will be undertaken over the next several years.
Article
The protective effect of mild hypothermia was studied in rodent models of both permanent and transient focal cerebral ischemia. In Expt. 1, Wistar rats were exposed to 6 h permanent ischemia by bilateral occlusion of both common carotid arteries and right middle cerebral artery. In Expt. 2, animals were exposed to 3 h transient ischemia followed by 21 h reperfusion, and in Expt. 3, 3 h transient ischemia was followed by 69 h of reperfusion. Expt. 4 used 3 h transient ischemia followed by 3 h reperfusion. In Expt. 1, animals maintained at 37 degrees C rectal (normothermia) suffered a mean infarct volume (+/- S.D.) of 142 +/- 44 mm3 (n = 6), which was reduced for those exposed to permanent hypothermic (32 degrees C) ischemia to 56 +/- 64 mm3 (n = 10) (P less than 0.05). In Expt. 2, normothermic ischemia and reperfusion resulted in an infarction of 211 +/- 35 mm3 (n = 6). Intra-ischemic hypothermia (32 degrees C) followed by 21 h of normothermic reperfusion resulted in 17 +/- 12 mm3 of infarction (n = 9) (P less than 0.001). Hypothermia for either the first or second 1.5 h of the 3 h ischemic insult reduced the infarct volume to 116 +/- 76 mm3 (n = 6) (P less than 0.05) or 108 +/- 73 mm3 (n = 7) (P less than 0.01), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Article
We describe a new rat model of temporary focal ischemia that produces neocortical ischemia without the need for prolonged anesthesia. Temporary focal cerebral ischemia was initiated during halothane anesthesia, maintained for varying periods without anesthesia, and reversed by clip removal requiring brief anesthesia. Tandem carotid and middle cerebral artery occlusion for 1-4 hours and permanent occlusion were used to determine the duration and extent of ischemia necessary to produce predictable volumes of neocortical infarction in Wistar and spontaneously hypertensive rats. In Wistar rats, occlusion of the right middle cerebral and both common carotid arteries resulted in cerebral blood flow reductions to approximately 8% of baseline. One hour of transient ischemia with 23 hours of reperfusion did not result in infarction. Three hours of ischemia followed by 21 hours of reperfusion resulted in infarction comparable to that caused by 24 hours of permanent ischemia. In spontaneously hypertensive rats, unilateral right middle cerebral and common carotid artery occlusion reduced cerebral blood flow to approximately 11% of baseline. Minimal damage was seen with 1 hour of reversible ischemia, but intervals of 2 and subsequently 3 hours followed by 22-21 hours of reperfusion produced progressively larger infarcts. Damage indistinguishable from that seen with 24 hours of permanent ischemia was seen with 3 or 4 hours of transient ischemia followed by 21 or 20 hours of reperfusion. For unanesthetized normothermic rats, cerebral blood flow reductions to 10-20% of baseline resulted in maximal infarction once ischemic durations exceeded 2-3 hours. To be effective, experimental therapies aimed at lessening infarct size or restoring blood flow must be initiated within this critical time interval.